OncoImmunology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2022-07-05 只想毕业

审稿速度:1.0
偏重的研究方向：肿瘤;生信;体内外实验验证
经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不

113 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2023-04-19 ms1000000858912769 来自湖北省

生信+实验这个杂志收吗？

50 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2022-05-05 ms4000001980332372

这个杂志还收纯生信的文章吗

79 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2023-11-25 ms8000000203882372 来自黑龙江省

偏重的研究方向：免疫
经验分享：请问这个杂志还收纯生信吗谢谢

36 0

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2020-03-01 147a5f5cm41(暂无昵称)

第一篇sci接收了开心

164 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2022-09-24 ms5000001856769052

请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业

79 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2023-03-06 3264907_6241 来自吉林省

为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2023-02-03 ms8000001862673965 来自上海

有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。

63 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2022-01-19 小胖子罗军

审稿速度:1.0
经验分享：2022.1.07 with editor
2022.1.07 out for review
2022.1.18 reviews complete
2022.1.18 decision pending
2022.1.19 悲剧
这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。

1 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1230729, encodeId=59661230e29b4, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信;体内外实验验证 经验分享：请问各位大神，泛癌生信分析+简单体内外实验验证可以投这个杂志不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Tue Jul 05 17:57:47 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127115, encodeId=d473212e1156d, content=生信+实验这个杂志收吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=261c5473647, createdName=ms1000000858912769, createdTime=Wed Apr 19 20:42:07 CST 2023, time=2023-04-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1217205, encodeId=66f9121e20541, content=这个杂志还收纯生信的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96255704488, createdName=ms4000001980332372, createdTime=Thu May 05 22:38:50 CST 2022, time=2022-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170901, encodeId=096521e09011c, content=偏重的研究方向：免疫 经验分享：请问这个杂志还收纯生信吗谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a18503343, createdName=ms8000000203882372, createdTime=Sat Nov 25 11:07:24 CST 2023, time=2023-11-25, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=585659, encodeId=23cf585659b3, content=第一篇sci接收了开心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/03/388106d423117cc1168724c51b80fa15.jpg, createdBy=c6ad5233418, createdName=147a5f5cm41(暂无昵称), createdTime=Sun Mar 01 00:00:00 CST 2020, time=2020-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090076, encodeId=f2c620900e614, content=请问各位大佬，with eidior一般多久送外审啊。投稿当天就with editor了，但是已经10天没有动静了，着急毕业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b6a8289282, createdName=ms5000001856769052, createdTime=Sat Sep 24 10:04:46 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117859, encodeId=dfa7211e8595b, content=为啥提交手稿的那个界面里，最后一步的收费，一直不能保存，导致一直不能提交！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61096439275, createdName=3264907_6241, createdTime=Mon Mar 06 08:31:04 CST 2023, time=2023-03-06, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2112929, encodeId=bb3d21129294e, content=有人知道那个5000字限制是怎么回事吗？我全文6500字，让我修改，但是我看发表的文章都超了5000字。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54348168716, createdName=ms8000001862673965, createdTime=Fri Feb 03 21:33:37 CST 2023, time=2023-02-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1185925, encodeId=5093118592532, content=审稿速度:1.0 经验分享：2022.1.07 with editor 2022.1.07 out for review 2022.1.18 reviews complete 2022.1.18 decision pending 2022.1.19 悲剧 这个杂志速度挺快的，投稿系统也不麻烦，但是投稿时候没有让提交cover letter 和推荐审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Wed Jan 19 09:40:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889524, encodeId=ae8588952480, content=修回一个月接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/27/95f4a711ca3a2b27feb769b3e2e65d19.jpg, createdBy=5b6f1926113, createdName=ms8000001455677582, createdTime=Thu Oct 01 00:25:21 CST 2020, time=2020-10-01, status=1, ipAttribution=)]

2020-10-01 ms8000001455677582

修回一个月接收

167 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务